Epstein Secrets

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, It Is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified a

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting LM'iit. Please refer to the Positive Findings section of the report for those compounds that were identified

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as

ynthetic Cannabinaids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid ChromatographyfTandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound Rpt Limit comccund Bgt Liroit 4-<:yano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-Huoro-MDMB-BINACA 0.10 ng/

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound Is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n